2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile waxaa loo isticmaalaa dhex dhexaadinta Trelagliptin succinate.
Trogliptin succinate waa dipeptidyl peptidase Ⅳ (DPP-Ⅳ) inhibitor ah oo ay soo saartay Takeda (Takeda Pharmaceutical Co., Ltd.) ee Japan.Waxay si xul ah oo joogto ah u joojin kartaa DPP - Ⅳ waxayna xakameyn kartaa heerka gulukooska dhiigga.Tijaabooyin caafimaad ayaa muujinaya in daawadu leedahay badbaado iyo waxtar wanaagsan.Toddobaadkiiba hal mar ayaa si wax ku ool ah u xakameyn kara heerka gulukoosta dhiigga waxayna wanaajin kartaa u hoggaansanaanta daawada bukaannada.Bishii Maajo, 2015, daawadu waxay ogolaatay Japan PMDA in lagu qoro daawaynta sonkorowga.